Real-time enrollment status for this neuroblastoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 8:15 AM UTC
| NCT Number | NCT06540963 |
| Recruiting Status | Recruiting |
| Condition | Neuroblastoma |
| Phase | PHASE2 |
| Target Enrollment | 98 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Giselle Sholler |
| Last Updated on CT.gov | April 28, 2026 (Apr 28, 2026) |
As of July 19, 2026: Clinical trial NCT06540963 is currently recruiting participants. This phase2 study for neuroblastoma is actively seeking new participants at 12 locations across the United States. The study is sponsored by Giselle Sholler. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06540963 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06540963 was last updated Apr 28, 2026 (April 28, 2026). HelloStudys verifies this status automatically.